DE10146647A1 - Arzneimittel zur Prophylaxe und Therapie von Bromhidrosis - Google Patents

Arzneimittel zur Prophylaxe und Therapie von Bromhidrosis

Info

Publication number
DE10146647A1
DE10146647A1 DE10146647A DE10146647A DE10146647A1 DE 10146647 A1 DE10146647 A1 DE 10146647A1 DE 10146647 A DE10146647 A DE 10146647A DE 10146647 A DE10146647 A DE 10146647A DE 10146647 A1 DE10146647 A1 DE 10146647A1
Authority
DE
Germany
Prior art keywords
botulinum toxin
body odor
sweat
skin
bromhidrosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE10146647A
Other languages
German (de)
English (en)
Inventor
Marc Heckmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to DE10146647A priority Critical patent/DE10146647A1/de
Priority to HU0401913A priority patent/HU230398B1/hu
Priority to EA200601238A priority patent/EA011988B1/ru
Priority to EP02781099.3A priority patent/EP1427385B1/de
Priority to CNB028185765A priority patent/CN1289061C/zh
Priority to KR1020047004120A priority patent/KR100796243B1/ko
Priority to CA002461117A priority patent/CA2461117C/en
Priority to EA200400436A priority patent/EA008146B1/ru
Priority to EP15179974.9A priority patent/EP2987483B1/de
Priority to UA20040402705A priority patent/UA78718C2/uk
Priority to PCT/DE2002/003561 priority patent/WO2003026602A2/de
Priority to AU2002349268A priority patent/AU2002349268B2/en
Priority to IL16087502A priority patent/IL160875A0/xx
Priority to PL373528A priority patent/PL209639B1/pl
Priority to MXPA04002614A priority patent/MXPA04002614A/es
Priority to US10/490,244 priority patent/US20050036966A1/en
Priority to JP2003530240A priority patent/JP4966478B2/ja
Publication of DE10146647A1 publication Critical patent/DE10146647A1/de
Priority to IL160875A priority patent/IL160875A/en
Priority to ZA200302123A priority patent/ZA200402123B/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A61K38/4893—Botulinum neurotoxin (3.4.24.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE10146647A 2001-09-21 2001-09-21 Arzneimittel zur Prophylaxe und Therapie von Bromhidrosis Ceased DE10146647A1 (de)

Priority Applications (19)

Application Number Priority Date Filing Date Title
DE10146647A DE10146647A1 (de) 2001-09-21 2001-09-21 Arzneimittel zur Prophylaxe und Therapie von Bromhidrosis
UA20040402705A UA78718C2 (en) 2001-09-21 2002-09-23 Use of botulinum toxin for preventing and treating bromidrosis
PCT/DE2002/003561 WO2003026602A2 (de) 2001-09-21 2002-09-23 Arzneimittel zur prophylaxe und therapie von bromhidrosis
EP02781099.3A EP1427385B1 (de) 2001-09-21 2002-09-23 Arzneimittel zur prophylaxe und therapie von bromhidrosis
CNB028185765A CN1289061C (zh) 2001-09-21 2002-09-23 用于预防和治疗臭汗症的药剂
KR1020047004120A KR100796243B1 (ko) 2001-09-21 2002-09-23 취한증의 예방 및 치료 약재
CA002461117A CA2461117C (en) 2001-09-21 2002-09-23 Botulinus toxin for treatment of body odour
EA200400436A EA008146B1 (ru) 2001-09-21 2002-09-23 Медикаменты для профилактики и лечения бромидроза и для улучшения запаха тела
EP15179974.9A EP2987483B1 (de) 2001-09-21 2002-09-23 Arzneimittel zur prophylaxe und therapie von bromhidrosis und dessen kosmetischen verwendung
HU0401913A HU230398B1 (hu) 2001-09-21 2002-09-23 Bromhidrosis kezelésére és megelőzésére szolgáló gyógyszerkészítmény
EA200601238A EA011988B1 (ru) 2001-09-21 2002-09-23 Медикаменты для профилактики и лечения бромидроза и для улучшения запаха тела
AU2002349268A AU2002349268B2 (en) 2001-09-21 2002-09-23 Medicine for preventing and treating bromidrosis
IL16087502A IL160875A0 (en) 2001-09-21 2002-09-23 The use of botulinus toxin for the manufacture of a medicament and a cosmetic
PL373528A PL209639B1 (pl) 2001-09-21 2002-09-23 Zastosowanie toksyny botulinowej typu A do wytwarzania leku do profilaktyki i/lub leczenia cuchnącego potu
MXPA04002614A MXPA04002614A (es) 2001-09-21 2002-09-23 Medicamento para prevenir y tratar bromidrosis.
US10/490,244 US20050036966A1 (en) 2001-09-21 2002-09-23 Medicine for preventing and treating bromidrosis
JP2003530240A JP4966478B2 (ja) 2001-09-21 2002-09-23 臭汗症の予防および治療のための薬剤
IL160875A IL160875A (en) 2001-09-21 2004-03-15 Use of botulinum toxin for the manufacture of a medicament and a cosmetic for treating body odors
ZA200302123A ZA200402123B (en) 2001-09-21 2004-03-17 Medicine for preventing and treating bromidrosis.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10146647A DE10146647A1 (de) 2001-09-21 2001-09-21 Arzneimittel zur Prophylaxe und Therapie von Bromhidrosis

Publications (1)

Publication Number Publication Date
DE10146647A1 true DE10146647A1 (de) 2003-04-24

Family

ID=7699852

Family Applications (1)

Application Number Title Priority Date Filing Date
DE10146647A Ceased DE10146647A1 (de) 2001-09-21 2001-09-21 Arzneimittel zur Prophylaxe und Therapie von Bromhidrosis

Country Status (16)

Country Link
US (1) US20050036966A1 (enExample)
EP (2) EP1427385B1 (enExample)
JP (1) JP4966478B2 (enExample)
KR (1) KR100796243B1 (enExample)
CN (1) CN1289061C (enExample)
AU (1) AU2002349268B2 (enExample)
CA (1) CA2461117C (enExample)
DE (1) DE10146647A1 (enExample)
EA (2) EA011988B1 (enExample)
HU (1) HU230398B1 (enExample)
IL (2) IL160875A0 (enExample)
MX (1) MXPA04002614A (enExample)
PL (1) PL209639B1 (enExample)
UA (1) UA78718C2 (enExample)
WO (1) WO2003026602A2 (enExample)
ZA (1) ZA200402123B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030113349A1 (en) 2001-12-18 2003-06-19 Coleman William P. Topically applied clostridium botulinum toxin compositions and treatment methods
EP2272340B1 (en) 2002-08-19 2018-03-14 Ira Sanders Botulinum toxin
US7335367B2 (en) * 2003-03-06 2008-02-26 Botulinum Toxin Research Associates, Inc. Treatment of chronic chalazion and hordeolum with botulinum toxin
US8048423B2 (en) * 2003-12-09 2011-11-01 Allergan, Inc. Botulinum toxin therapy for skin disorders
KR20070110402A (ko) * 2005-03-03 2007-11-16 레반스 테라퓨틱스 보툴리눔 독소의 국소 적용 및 경피 전달을 위한 조성물 및방법
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
CN101848702B (zh) 2006-12-01 2013-07-17 安特里奥公司 两亲实体纳米粒子
MX2010013562A (es) * 2008-06-26 2011-02-15 Anterios Inc Aplicacion dermica.
US8454975B1 (en) * 2010-01-11 2013-06-04 Elizabeth VanderVeer Method for enhancing skin appearance
EP3541358A1 (en) 2016-11-21 2019-09-25 Eirion Therapeutics, Inc. Transdermal delivery of large agents
US11191819B2 (en) 2018-08-28 2021-12-07 Ira Sanders Skin therapeutics
WO2020056191A1 (en) 2018-09-13 2020-03-19 Eirion Therapeutics, Inc. Uses of plasminogen activator inhibitor 1 (pai-1) inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19852981A1 (de) * 1998-11-17 2000-05-18 Martin Schmidt Botulinum-Toxine, deren Derivate, Analoge und molekulare Bruchstücke zur topischen epicutanen Anwendung auch in Zusammenwirken mit hautpenetrationsfördernden Substanzen und Maßnahmen in Zubereitungsformen zur Beeinflussung acetylcholinabhängiger Körperfunktionen
US20020086036A1 (en) * 2000-12-05 2002-07-04 Allergan Sales, Inc. Methods for treating hyperhidrosis
US20030113349A1 (en) * 2001-12-18 2003-06-19 Coleman William P. Topically applied clostridium botulinum toxin compositions and treatment methods

Also Published As

Publication number Publication date
EP1427385B1 (de) 2015-09-23
IL160875A (en) 2010-11-30
PL209639B1 (pl) 2011-09-30
KR20040048895A (ko) 2004-06-10
EA200400436A1 (ru) 2007-02-27
AU2002349268B2 (en) 2007-12-13
WO2003026602A3 (de) 2003-08-28
MXPA04002614A (es) 2005-02-17
EP2987483B1 (de) 2020-12-02
UA78718C2 (en) 2007-04-25
JP2005507888A (ja) 2005-03-24
EA008146B1 (ru) 2007-04-27
HUP0401913A3 (en) 2008-02-28
JP4966478B2 (ja) 2012-07-04
CA2461117A1 (en) 2003-04-03
US20050036966A1 (en) 2005-02-17
EA011988B1 (ru) 2009-06-30
PL373528A1 (en) 2005-09-05
CA2461117C (en) 2009-12-08
CN1556693A (zh) 2004-12-22
EA200601238A1 (ru) 2007-06-29
HU230398B1 (hu) 2016-04-28
KR100796243B1 (ko) 2008-01-21
EP2987483A1 (de) 2016-02-24
HUP0401913A2 (hu) 2005-01-28
IL160875A0 (en) 2004-08-31
ZA200402123B (en) 2004-10-04
WO2003026602A2 (de) 2003-04-03
CN1289061C (zh) 2006-12-13
EP1427385A2 (de) 2004-06-16

Similar Documents

Publication Publication Date Title
EP2987483B1 (de) Arzneimittel zur prophylaxe und therapie von bromhidrosis und dessen kosmetischen verwendung
DE10150415A1 (de) Arzneimittel zur Prophylaxe und Therapie von Depressionen
DE60001918T2 (de) Kosmetische zusammensetzung auf der basis von menthol und menthyllactat, die einen geringen geruch aufweist und nicht reizt
EP0668768B1 (de) Zusammensetzung zur bekämpfung von dermatomykosen und deren erregern sowie von schweissbildung und körpergeruch
DE19754659A1 (de) Verwendung von Kohlensäure zur Stabilisierung oder Erhöhung der epidermalen Ceramidsyntheserate
EP3654932A1 (de) Tyrothricin zur anwendung bei der behandlung oder prophylaxe von körpergeruch sowie zubereitungen hierfür
CN101822621B (zh) 一种消除狐臭的外用液
DE102018106331A1 (de) Bakterien umfassende Zusammensetzung zur Geruchsreduzierung
WO1999061045A1 (de) Topisch anwendbares arzneimittel zur behandlung von virusinfektionen
JP2000290163A (ja) 保湿クリーム
DE102009052808A1 (de) Eine Heilsalbe mit mindestens einem homöopathisch verdünnten Mineralsalz
DE102016006816A1 (de) Antitranspirante Lösung ohne lösliche Aluminiumsalze
JPS5883612A (ja) 防臭防汗用塗布剤
DE102012223553A1 (de) Verwendung von Aluminiumsalzen gegen Stress-Schwitzen
EP2008638A1 (de) Sauerstoff in kosmetischen oder dermatologischen Zubereitungen
DE4304284A1 (de) Deodorierendes Mittel
EP2842543B1 (de) Zusammensetzung mit Kühlwirkung für die topische Anwendung
CN121512867A (zh) 除臭露
DE202016003503U1 (de) Antitranspirante Lösung ohne lösliche Aluminiumsalze
Zernecke Effects of male sweat on human physiology and behavior
JPH0656649A (ja) 浴用剤組成物
JPH01125326A (ja) 細菌性表皮疾患治療薬
KR20050072899A (ko) 항균비누 조성물
DE102018006887A1 (de) Mittel zur Mund- und Zahnpflege
DE1814315B2 (de) Hautpflegemittel

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
8127 New person/name/address of the applicant

Owner name: ALLERGAN INC. (N.D.GES.D. STAATES DELAWARE), IRVIN

8128 New person/name/address of the agent

Representative=s name: DEHMEL & BETTENHAUSEN, de

8181 Inventor (new situation)

Inventor name: HECKMANN, MARC, 82343 POECKING, DE

R082 Change of representative

Representative=s name: HOFFMANN - EITLE PATENT- UND RECHTSANWAELTE PA, DE

R079 Amendment of ipc main class

Free format text: PREVIOUS MAIN CLASS: A61K0035740000

Ipc: A61K0035742000

R079 Amendment of ipc main class

Free format text: PREVIOUS MAIN CLASS: A61K0035740000

Ipc: A61K0035742000

Effective date: 20141128

R016 Response to examination communication
R002 Refusal decision in examination/registration proceedings
R003 Refusal decision now final